News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 217–252
- Matches
- 802
- Sources here
- 15
- Companies here
- 16
Active search
802 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Diversified Management Inc. Trims Stock Position in Citigroup Inc. $C
Diversified Management Inc. significantly reduced its stake in Citigroup Inc. by 85.4% in the second quarter, selling over 10,000 shares. Despite this, institutional ownership remains high at 71.72%, and analysts maintain a "Moderate Buy" rating for Citigroup, with an average price target of $145.22. …
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
Citius Oncology, a biopharmaceutical company, announced the appointment of Jonathan Peri, Ph.D., J.D., as an independent director to its Board, expanding it to nine members. Dr. Peri brings extensive leadership experience in higher education, financial services, law, and corporate governance, which is expected to …
Sharemaestro market context Price above Trend Line 52 weeks -48.0%C6480247 Bond Price and Chart — FINRA:C6480247
This article provides detailed financial information for the Citigroup Global Markets Holdings Inc. 5.2% bond maturing on August 20, 2031 (FINRA:C6480247). It includes key terms such as outstanding amount, face value, coupon rate, and term to maturity, along with issuer details and various identifiers. …
Citizens Financial (CFG): Capital World Investors reports 5.6% stake in common stock
Capital World Investors has filed an amended ownership report disclosing a 5.6% beneficial stake in Citizens Financial Group, Inc., amounting to 23,539,168 shares of common stock. The filing indicates that Capital World Investors holds sole voting power over 23,249,957 shares and sole dispositive power …
Citizens Financial Group Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Citizens Financial Group Inc. (CFG) stock increased by 1.26% on Wednesday, closing at $73.91, despite a mixed trading session for the broader market. While the S&P 500 Index saw gains, the Dow Jones Industrial Average slightly declined. This marks the second consecutive day of …
Price to sales forward of Citizens Financial Services, Inc. – NASDAQ:CZFS
This article provides a brief overview of the "Price to sales forward" metric for Citizens Financial Services, Inc. (NASDAQ: CZFS). It presents this financial data point within the TradingView platform context, indicating its period, value, and change.
Citizens, Inc. (CIA) CEO Jon Stenberg purchases 12,000 shares in open market
Citizens, Inc. CEO Jon Stenberg has purchased 12,000 shares of Class A common stock on the open market at $3.6496 per share. This transaction, filed on August 12, 2026, increased his direct holdings to 389,574 shares, with an additional 130,100 shares held indirectly through …
Citigroup affirms Excelerate Energy's Outperform rating after strong Q2 with raised EBITDA forecast.
Citigroup has reaffirmed its Outperform rating on Excelerate Energy following strong Q2 2026 results, which saw net income of $50.1 million and adjusted EBITDA of $120.1 million, surpassing estimates. The company raised its full-year adjusted EBITDA forecast to $490-$515 million, driven by new projects …
Citigroup Inc. stock outperforms competitors on strong trading day
Citigroup Inc. stock (C) rose by 1.33% to $137.58 on Wednesday, outperforming the mixed market, with the S&P 500 Index gaining 0.26% and the Dow Jones Industrial Average falling 0.04%. This marks the fourth consecutive day of gains for the stock.
Is Citigroup (C) Undervalued After Its Latest Bond Offerings?
Citigroup (C) has been active in the bond market with new bond offerings. Despite a recent slight dip in share price, its 1-year total shareholder return is strong, leading to a "Most Popular Narrative" that values the stock at $154.00, suggesting it is undervalued. …
Form 8K Citius Oncology Inc For: 12 August By Investing.com
This article announces the filing of a Form 8K by Citius Oncology Inc. on August 12, 2026. The content is brief and primarily serves as a news alert for the filing, with a focus on market data and other news. Citius Oncology Inc. (CTOR) …
Citius Oncology appoints Jonathan Peri to board of directors By Investing.com
Citius Oncology, Inc. has appointed Jonathan Peri, Ph.D., J.D., as an independent director to its board, expanding it to nine members. Peri brings 30 years of experience in higher education, financial services, law, and corporate governance. The company, a subsidiary of Citius Pharmaceuticals, Inc., …
Citius Oncology appoints Jonathan Peri to board of directors
Citius Oncology, a subsidiary of Citius Pharmaceuticals, has appointed Jonathan Peri, Ph.D., J.D., as an independent director to its board. This appointment expands the board to nine members. Peri brings extensive experience in higher education, financial services, law, and corporate governance to the role.
Wedge Capital Management L L P NC Lowers Stake in Citigroup Inc. $C
Wedge Capital Management L L P NC reduced its stake in Citigroup Inc. by 6.7% in the second quarter, selling 18,194 shares and now holding 254,560 shares valued at $35.6 million. Despite this reduction, Citigroup reported strong quarterly results with higher-than-expected EPS and revenue, …
Northside Capital Management LLC Reduces Holdings in Citigroup Inc. $C
Northside Capital Management LLC reduced its stake in Citigroup Inc. by 28.4% in the second quarter, selling 34,091 shares and retaining 85,841 shares valued at approximately $12.0 million. Despite this, institutional investors own a significant 71.72% of Citigroup. The company recently reported strong quarterly …
Citigroup Adjusts Price Target on Howmet Aerospace to $329 From $311, Keeps Buy Rating
Citigroup has raised its price target for Howmet Aerospace (HWM) to $329 from $311, while maintaining a Buy rating on the stock. This adjustment reflects an updated outlook from the financial firm on the aerospace company's valuation. The report was published by MT Newswires …
Citizens Inc. president & CEO Jon Stenberg buys $199,630 in stock
Citizens Inc. President & CEO Jon Stenberg recently purchased 50,000 shares of the company's Class A Common Stock for a total of $199,630. This transaction occurred on August 10, 2026, when the stock was trading near its 52-week low. Stenberg now directly and indirectly …
Citigroup Inc. Trims Wolfspeed Inc (WOLF) Stake by 78% in June 2
Citigroup Inc. significantly reduced its stake in Wolfspeed Inc (WOLF) by 78.01% on June 30, 2026, selling over 2.5 million shares at $48.25 each. This move, which leaves Citigroup with a 1.40% ownership stake, reflects a reassessment of Wolfspeed's prospects given its weak financial …
Citizens, Inc. Class A Revenue Breakdown – LS:694147
This article provides a revenue breakdown for Citizens, Inc. Class A (LS:694147), detailing its top-performing segments and regional contributions. Last year, the company generated €217.52 million, with International Insurance being the primary segment, contributing €149.56 million. The United States was the largest geographical contributor, …
First Citizens BancShares (FCNCA) family group updates 24.89% Class A ownership
Members of the Holding/Bryant/Bristow/Brice family group have filed an updated Schedule 13D/A, indicating a beneficial ownership of approximately 24.89% of First Citizens BancShares' (FCNCA) Class A Common Stock as of August 7, 2026. This amendment primarily reflects increased ownership percentages due to issuer share …
Citi Trends Sees Q2 Comps Expand 10.5 Percent
Citi Trends reported preliminary Q2 2026 results showing a 10.5 percent increase in comparable store sales, leading to a 10.9 percent rise in total sales to $211.6 million. This marks the eighth consecutive quarter of comparable store sales growth, attributed to strategic transformation, enhanced …
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup
Citigroup has reduced its price target for Health Catalyst (NASDAQ:HCAT) from $2.50 to $2.00, while maintaining a "neutral" rating, indicating a potential 12% upside from its previous close. Despite beating quarterly EPS and revenue estimates, the company continues to report substantial losses, and analysts …
IPG Photonics (NASDAQ:IPGP) Given New $137.00 Price Target at Citigroup
Citigroup has lowered its price target for IPG Photonics (NASDAQ:IPGP) from $150.00 to $137.00 but maintained a "buy" rating, indicating a potential upside of approximately 59% from its current share price. The company recently reported strong quarterly earnings, beating analyst expectations with $0.58 EPS …
Citigroup Has Lowered Expectations for Lumen Technologies (NYSE:LUMN) Stock Price
Citigroup has lowered its price target for Lumen Technologies (NYSE:LUMN) from $10.00 to $8.25, while maintaining a neutral rating, indicating a potential upside of 29.4%. Other analysts have also adjusted their targets, with a consensus "Reduce" rating and an average price target of $7.86. …
Oceaneering International (NYSE:OII) Price Target Raised to $52.00 at Citigroup
Citigroup has increased its price target for Oceaneering International (NYSE:OII) to $52.00 from $40.00, maintaining a "neutral" rating on the stock. This new target implies a potential upside of 2.54% from the previous closing price. Despite the upgrade from Citigroup and others, the company …
P Upgraded by Citigroup -- Price Target Raised to $118
Citigroup has upgraded Everpure Inc (P) to a 'Buy' rating from 'Neutral', raising the price target to $118.00, indicating a potential upside of 31.11%. Despite this positive analyst outlook, GuruFocus assesses P as 45.6% overvalued with a current price of $107.30 against a GF …
Citigroup Lowers Matador Resources (NYSE:MTDR) Price Target to $60.00
Citigroup has reduced its price target for Matador Resources (NYSE:MTDR) from $68.00 to $60.00, while maintaining a "buy" rating, indicating a potential 14.18% upside. Despite this adjustment, analyst sentiment remains a "Moderate Buy" with a consensus price target of $65.29. The company recently reported …
Did Citi’s New Infor Nexus–Powered Trade Platform Quietly Reframe Its Digital Strategy Narrative (C)?
Citigroup Inc. recently launched Citi Consolidate™, an Infor Nexus–powered platform for invoice processing and supply chain finance, now available in the US and Canada. This new digital trade solution integrates automated invoice workflows, cash-flow visibility, and supplier financing, reinforcing Citi's digital trade finance strategy. …